Clinical Features of Migraine and Other Headache Disorders
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Read PDF Edition
REVIEW OF OPTOMETRY EARN 2 CE CREDITS: Positive Visual Phenomena—Etiologies Beyond the Eye, PAGE 58 ■ VOL. 155 NO. 1 January 15, 2018 www.reviewofoptometry.comwww.reviewofoptometry.com ■ ANNUAL CORNEA REPORT JANUARY 15, 2018 ■ CXL ■ EPITHELIAL DEFECTS How to Heal Persistent Epithelial Defects PAGE 38 ■ TRANSPLANTS Corneal Transplants: The OD’s Role PAGE 44 ■ INFILTRATES Diagnosing Corneal Infiltrative Disease PAGE 50 ■ POSITIVE VISUAL PHENOMENA CXL: Your Top 12 Questions —Answered! PAGE 30 001_ro0118_fc.indd 1 1/5/18 4:34 PM ĊčĞĉėĆęĊĉĆĒēĎĔęĎĈĒĊĒćėĆēĊċĔėĎēǦĔċċĎĈĊĕėĔĈĊĉĚėĊĘ ĊđĎĊċĎēĘĎČčę ċċĊĈęĎěĊ Ȉ 1 Ȉ 1 ĊđđǦęĔđĊėĆęĊĉ Ȉ Ȉ ĎĒĕđĊĎēǦĔċċĎĈĊĕėĔĈĊĉĚėĊ Ȉ Ȉ ĔēěĊēĎĊēę Ȉ͝ Ȉ Ȉ Ƭ 1 ǡ ǡǡǤ͚͙͘͜Ǥ Ȁ Ǥ ͚͙͘͜ǣ͘͘ǣ͘͘͘Ǧ͘͘͘ ĕĕđĎĈĆęĎĔēĘ Ȉ Ȉ Ȉ Ȉ Ȉ čĊĚėĎĔē̾ėĔĈĊĘĘ Ȉ Ȉ Katena — Your completecomplete resource forfor amniotic membrane pprocedurerocedure pproducts:roducts: Single use speculums Single use spears ͙͘͘ǡ͘͘͘ήĊĞĊĘęėĊĆęĊĉ Forceps ® ,#"EWB3FW XXXLBUFOBDPNr RO0118_Katena.indd 1 1/2/18 10:34 AM News Review VOL. 155 NO. 1 ■ JANUARY 15, 2018 IN THE NEWS Accelerated CXL Shows The FDA recently approved Luxturna (voretigene neparvovec-rzyl, Spark Promise—and Caution Therapeutics), a directly administered gene therapy that targets biallelic This new technology is already advancing, but not without RPE65 mutation-associated retinal dystrophy. The therapy is designed to some bumps in the road. deliver a normal copy of the gene to By Rebecca Hepp, Managing Editor retinal cells to restore vision loss. While the approval provides hope for patients, wo new studies highlight the resulted in infection—while tradi- the $425,000 per eye price tag stands as pros and cons of accelerated tional C-CXL has a reported inci- a signifi cant hurdle. -
Migraine Triggered Seizures and Epilepsy Triggered Headache and Migraine Attacks: a Need for Re-Assessment
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by PubMed Central J Headache Pain (2011) 12:287–288 DOI 10.1007/s10194-011-0344-2 COMMENTARY Migraine triggered seizures and epilepsy triggered headache and migraine attacks: a need for re-assessment Paul T. G. Davies • C. P. Panayiotopoulos Received: 5 April 2011 / Accepted: 8 April 2011 / Published online: 24 April 2011 Ó The Author(s) 2011. This article is published with open access at Springerlink.com In this issue of the Journal, Belcastro and associates review Migralepsy terminology and classification issues for migralepsy, hem- icrania epileptica, post-ictal and ictal headache [1]. They According to the ICHD-II 1.5.5, ‘‘migraine-triggered sei- raise key points such as ictal headache and visual seizures zure (sometimes referred to as migralepsy)’’ denotes an are often misdiagnosed as migraine, ‘‘migralepsy’’ is unli- epileptic seizure that occurs ‘‘during or within one hour kely to exist and an ‘‘epilepsy-migraine sequence’’ is much after a migraine aura’’ [3]. However, the evidence of this more common and well documented than the dominant ‘‘migraine-seizure’’ sequence is weak and the proposed view of a ‘‘migraine-epilepsy sequence’’. Their relevant criterion of 1 h gap between the end of the ‘‘aura’’ and the proposals need appropriate attention by the committee of start of an epileptic seizure is entirely arbitrary the international classification of headache disorders Migralepsy is an old term derived from migra(ine) and (ICHD) as well as the physicians in their clinical practice (epi)lepsy, coined by Dr Douglas Davidson, but mainly because of the consequences that misdiagnosis may have on attributed to Lennox and Lennox, which we quote, ‘‘a patients. -
Elementary Visual Hallucinations, Blindness, and Headache in Idiopathic Occipital Epilepsy: Diverentiation from Migraine
536 J Neurol Neurosurg Psychiatry 1999;66:536–540 J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.66.4.536 on 1 April 1999. Downloaded from SHORT REPORT Elementary visual hallucinations, blindness, and headache in idiopathic occipital epilepsy: diVerentiation from migraine C P Panayiotopoulos Abstract also fundamental symptoms often with the This is a qualitative and chronological same sequence of events in occipital seizures.1−9 analysis of ictal and postictal symptoms, This is a systematic prospective qualitative frequency of seizures, family history, study of the characteristics of elementary visual response to treatment, and prognosis in hallucinations, blindness, and headache in nine patients with idiopathic occipital epi- idiopathic occipital epilepsy. lepsy and visual seizures. Ictal elementary visual hallucinations are stereotyped for Methods each patient, usually lasting for seconds. These are detailed elsewhere.910 Patients with They consist of mainly multiple, bright occipital seizures were prospectively evaluated coloured, small circular spots, circles, or and followed up from 1973. Nine patients with balls. Mostly, they appear in a temporal idiopathic occipital epilepsy with visual halluci- hemifield often moving contralaterally or nations (IOEVH) had: in the centre where they may be flashing. (a) Incontrovertible clinical evidence of oc- They may multiply and increase in size in cipital seizures with or without secondarily the course of the seizure and may progress generalisation. to other non-visual occipital seizure (b) Normal physical, neurological, and men- symptoms and more rarely to extra- tal states and high resolution MRI. They all had detailed interviews, seven com- occipital manifestations and convulsions. 9 Blindness occurs usually from the begin- pleted a purposely designed questionnaire, ning and postictal headache, often indis- and eight provided drawings of their visual hal- tinguishable from migraine, is common. -
Hemicrania Continua
P1: KWW/KKL P2: KWW/HCN QC: KWW/FLX T1: KWW GRBT050-102 Olesen- 2057G GRBT050-Olesen-v6.cls August 17, 2005 1:36 ••Chapter 102 ◗ Hemicrania Continua Juan A. Pareja and Peter J. Goadsby Hemicrania continua (HC) is a syndrome characterized by est changes similar to those seen in PH (2). Most recently, a a unilateral, moderate, fluctuating, continuous headache, positron emission tomography (PET) study indicated sig- absolutely responsive to indomethacin. HC is relatively nificant activation of the contralateral posterior hypotha- featureless except during exacerbations, when both mi- lamus and ipsilateral dorsal rostral pons in association grainous symptoms and cranial autonomic symptoms may with the headache of HC. These areas corresponded with be present (31,38). “Hemicrania continua” was described those active in CH and migraine, respectively. In addition, by Sjaastad and Spierings (38). Relatively long-lasting uni- there was activation of the ipsilateral ventrolateral mid- lateral headaches responsive to indomethacin were re- brain, which extended over the red nucleus and the sub- ported by Medina and Diamond under “cluster headache stantia nigra, and of the bilateral pontomedullary junction. variant” (23), and Boghen and Desaulniers under “back- No intracranial vessel dilation was obvious (22). The data ground vascular headache” (10). suggest that HC, like migraine and CH, is fundamentally a brain disorder and further that its pathophysiology may International Headache Society (IHS) code number: be completely unique. This would fit with the clinical pre- 4.7 (17) sentation that has similarities to other primary headaches World Health Organization (WHO) code and diagnosis: but indeed seems unique. G44.80 Other primary headaches CLINICAL FEATURES EPIDEMIOLOGY HC is a unilateral, continuous headache, without side The incidence and prevalence of HC is not known. -
Trigeminal Autonomic Cephalalgias CQ IV-1
IV Trigeminal autonomic cephalalgias CQ IV-1 How are trigeminal autonomic cephalalgias classified and typed? Recommendation The International Classification of Headache Disorders 3rd Edition (beta version; ICHD-3 beta) classifies cluster headache together with related diseases under “Trigeminal autonomic cephalalgias”. Furthermore, “Trigeminal autonomic cephalalgias” is further divided into five subtypes: cluster headache, paroxysmal hemicrania, short-lasting unilateral neuralgiform headache attacks, hemicrania continua and probable trigeminal autonomic cephalalgia. Grade A Background and Objective The objective of this section is to classify Trigeminal“ autonomic cephalalgias” according to the International Classification of Headache Disorders 3rd Edition (beta version; ICHD-3 beta).1)2) Comments and Evidence Cluster headache and related diseases are characterized by short-lasting, unilateral headache attacks accompanied by cranial parasympathetic autonomic symptoms including conjunctival injection, lacrimation, and rhinorrhea. These syndromes support the involvement of trigeminal-parasympathetic reflex activation, and ICHD-3 beta introduces the concept of trigeminal autonomic cephalalgias (TACs) (Table 1). TACs comprise the following subtypes: 3.1 cluster headache, 3.2 paroxysmal hemicrania, 3.3 short-lasting unilateral neuralgiform headache attacks, 3.4 hemicrania continua, and 3.5 probable trigeminal-autonomic cephalalgia. Table 1. Classification of “3.Trigeminal autonomic cephalalgias” 3.1 Cluster headache 3.1.1 Episodic cluster -
Visual Perceptual Abnormalities: Hallucinations and Illusions John W
SEMINARS IN NEUROLOGY—VOLUME 20, NO. 1 2000 Visual Perceptual Abnormalities: Hallucinations and Illusions John W. Norton, M.D.* and James J. Corbett, M.D.‡,§ ABSTRACT Visual perceptual abnormalities may be caused by diverse etiologies which span the fields of psychiatry and neurology. This article reviews the differential diagnosis of visual perceptual abnormalities from both a neurological and a psychiatric perspec- tive. Psychiatric etiologies include mania, depression, substance dependence, and schizophrenia. Common neurological causes include migraine, epilepsy, delirium, dementia, tumor, and stroke. The phenomena of palinopsia, oscillopsia, dysmetrop- sia, and polyopia among others are also reviewed. A systematic approach to the many causes of illusions and hallucinations may help to achieve an accurate diag- nosis, and a more focused evaluation and treatment plan for patients who develop visual perceptual abnormalities. This article provides the practicing neurologist with a practical understanding and approach to patients with these clinical symptoms. Keywords: Illusion, hallucination, perceptual abnormalities, oscillopsia, polyopia, diplopia, palinopsia, dysmetropsia, visual allesthesia, visual synthesia, visual dyses- thesia, sensation of environmental tilt, psychiatric, neurological The topic of visual perceptual abnormalities, spe- enable the clinician to understand the phenomenology cifically hallucinations and illusions, spans many fields while diagnosing and treating patients who present with of medicine. The most prominent among these are neu- these problems. rology, ophthalmology, and psychiatry. A wide variety of An illusion is the misperception of a stimulus that is pathological processes can lead to perceptual abnormali- present in the external environment.1 An example is ties. The purpose of this presentation is to review the when an elderly demented individual interprets a chair in neurological and psychiatric differential diagnoses of vi- a poorly lit room as a person. -
Referral Criteria for Headache Referrals to Secondary Care
Headache pathway Referral criteria for headache referrals to secondary care Key points When to refer to a Specialist (Consider referring to ED depending on presentation and waiting OPD time) • Migraine, TTH and MOH are most common headache disorders and in most cases Diagnostic uncertainty, including unclassifiable, atypical headache not difficult to manage → initial primary care management recommended • Good management of most headache disorders requires monitoring over time Diagnosis of any of the following: • History is all-important, there is no useful diagnostic test for primary headache • Chronic migraine (patients who have failed at least one preventative agent) disorders and MOH • Cluster headache • Headache diaries (over few weeks) are essential to clarify pattern and frequency of • SUNCT/SUNA> headaches, associated symptoms, triggers, medication use/overuse • Persistent idiopathic facial pain • Special investigations, including neuroimaging, are not indicated unless the history/ examination suggest secondary headache • Hemicrania continua/chronic paroxismal hemicranias • Sinuses, refractive error, arterial hypertension and cervicogenic problems are not • Trigeminal neuralgia usually causes of headaches Suspicion of a serious secondary headache (Red flags) • Opioids (including codeine and dihydrocodeine) not to be prescribed in migraine • Progressive headache, worsening over weeks or longer Assessment of patients with headache • Headache triggered by coughing, exercise or sexual activity • Full history, including: Headache associated -
Chronic Daily Headache
Chronic Daily Headache David Dodick, MD Mayo Clinic, Scottsdale, AZ Esma Dilli, MD University of British Columbia, Vancouver, Canada Chronic Daily Headache (CDH) is a headache of any type occurring 15 or more days per month. It may be primary or secondary (due to underlying disorder). Important characteristics to determine if a patient has a secondary cause for their headaches include: systemic symptoms (fever, weight loss), secondary risk factors (HIV, systemic cancer), neurological symptoms or signs including papilledema, peak onset of pain in less than 1 minute, onset after age 50 years, or a headache precipitated by cough, exertion, valsalva or changes in position. CDH is sub-classified into short duration (< 4 hours) or long duration (> 4 hours) based on the duration of individual episodes. Short duration CDH include chronic cluster headache, chronic paroxysmal hemicrania, hypnic headache and idiopathic stabbing headache. Long duration CDH includes chronic migraine (CM), chronic tension type headache (CTTH), new daily persistent headache (NDPH), medication-overuse headache (MOH) and hemicrania continua. The prevalence of CDH is about 4%. The two most common primary chronic daily headaches are CTTH and CM. In a study examining the one year prognosis of migraine, chronic migraine occurred in 3% of all migraine suffers 1. In the American Migraine Prevalence and Prevention Study (AMPPS), the population based prevalence rates of CM are 0.67% with CM suffers consuming three times more costs/resources than episodic migraine suffers 2. Persons with CM had significant higher odds of greater adverse headache impact (based on HIT-6 scores) compared to episodic migraine. Predictors of high headache impact include average severity and depression 3. -
Migraine Aura Without Headache Donald M
B rief Reports Migraine Aura Without Headache Donald M. Pedersen, PA-C, PhD, William M. Wilson, PhD, George L. White, Jr, PA-C PhD Richard T. Murdock, MS/HSA, and Kathleen B. Digre, MD Salt Lake City, Utah Migraine is described as a familial disorder characterized to the disturbance described. The patient also denies by recurrent headaches that are variable in intensity, antecedent trauma or emotional stress. The episodes arc frequency, and duration.1 Attacks are usually unilateral reportedly always similar in nature, with an expanding but can also be bilateral and accompanied by throbbing scintillating scotoma and without subsequent headache, pain, photophobia, phonophobia, nausea, and vomiting. The patient’s first episode, his m ost recent episode, and Some migraines are preceded by, or are associated with, “a few” of the others have occurred after a 60-minutc neurological and mood disturbances. All of the above exercise period, which he performs consistently as a mat characteristics, however, are not necessarily present in ter of his daily routine. There is a history of myopia, for each attack, nor in each patient.2 correction o f which soft contact lenses are used, and It has been suggested that die prevalence of mi numerous vitreous floaters have been reported. The pa graine is probably markedly underestimated. Estimates tient takes no medication, has no history of illicit drug range from 10% to 34% of the general population, with use, and is otherwise healthy except for a history of mild some authors reporting both age-related and sex-related seasonal allergic rhinitis. There is a family history of differences. -
Side-Locked Headaches: an Algorithm-Based Approach Sanjay Prakash1,2* and Chaturbhuj Rathore1
Prakash and Rathore The Journal of Headache and Pain (2016) 17:95 The Journal of Headache DOI 10.1186/s10194-016-0687-9 and Pain REVIEW ARTICLE Open Access Side-locked headaches: an algorithm-based approach Sanjay Prakash1,2* and Chaturbhuj Rathore1 Abstract The differential diagnosis of strictly unilateral hemicranial pain includes a large number of primary and secondary headaches and cranial neuropathies. It may arise from both intracranial and extracranial structures such as cranium, neck, vessels, eyes, ears, nose, sinuses, teeth, mouth, and the other facial or cervical structure. Available data suggest that about two-third patients with side-locked headache visiting neurology or headache clinics have primary headaches. Other one-third will have either secondary headaches or neuralgias. Many of these hemicranial pain syndromes have overlapping presentations. Primary headache disorders may spread to involve the face and / or neck. Even various intracranial and extracranial pathologies may have similar overlapping presentations. Patients may present to a variety of clinicians, including headache experts, dentists, otolaryngologists, ophthalmologist, psychiatrists, and physiotherapists. Unfortunately, there is not uniform approach for such patients and diagnostic ambiguity is frequently encountered in clinical practice. Herein, we review the differential diagnoses of side-locked headaches and provide an algorithm based approach for patients presenting with side-locked headaches. Side-locked headache is itself a red flag. So, the first priority should be to rule out secondary headaches. A comprehensive history and thorough examinations will help one to formulate an algorithm to rule out or confirm secondary side-locked headaches. The diagnoses of most secondary side-locked headaches are largely investigations dependent. -
Headache Medicine: a Crossroads of Otolaryngology, Ophthalmology, and Neurology
FEATURE STORY NEURO-OPHTHALMOLOGY Headache Medicine: a Crossroads of Otolaryngology, Ophthalmology, and Neurology Numerous symptoms can suggest both ophthalmological and neurological disorders. BY PAUL G. MATHEW, MD, FAHS rimary headaches are a set of complex pain disor- part of the diagnostic criteria for migraine, in a study of ders that can have a heterogeneous presentation. 786 migraine patients (625 women, 61 men), 56% of the Some of these presentations can often involve subjects experienced autonomic symptoms, but these symptoms that suggest otolaryngological and symptoms tended to be bilateral.2 Pophthalmological diagnoses. In this second installment In addition to pain around the orbit, migraines can of a two-part series, the symptoms and diagnoses that also commonly involve blurry vision,3 which tends to overlap between ophthalmology and neurology will be occur during the headache phase of the migraine and addressed (please see the March 2014 issue of Cataract increases as the intensity of the pain peaks. Blurry vision & Refractive Surgery Today for the otolaryngology install- should not be confused with migraine visual aura. Visual ment of this series). The two main complaints that auras by definition are fully reversible, homonymous patients present with for ophthalmology consultations visual symptoms that can involve positive features are eye pain and visual disturbances. When ophthalmo- (scintillating scotomas, fortification spectrum) and/or logical evaluations including slit-lamp examinations and negative features (areas of visual loss). Visual auras typi- tonometry are unremarkable, other diagnostic possibili- cally last from 5 to 60 minutes and can be accompanied ties should be considered. by other aura phenomena in succession such as sensory or speech disturbances.1 A major misconception about MIGRAINE AND CLUSTER HEADACHE migraine aura is that it must occur prior to the onset The numerous causes of eye pain include blepharitis, of the headache. -
BRAINSTORM a CME-ACCREDITED COLLABORATIVE SYMPOSIUM on DIAGNOSING and TREATING MIGRAINE Contents
AMERICAN HEADACHE SOCIETY PRIMARY CARE MIGRAINE PARTNERSHIP BRAINSTORM A CME-ACCREDITED COLLABORATIVE SYMPOSIUM ON DIAGNOSING AND TREATING MIGRAINE Contents Introduction . .1 Attendee Information for CME Credit . .5 Module 1: Prevalence and Impact of Migraine . .9 Module 2: Migraine Mechanisms . .17 Module 3: History, Physical and Diagnosis . .25 Module 4: Migraine Management . .51 Conclusions . .77 Appendix . .78 Evidence-Based Guidelines for Migraine Headache . .78 Patient Treatment Plan . .84 International Headache Society, ICD-10 Guide for Headaches . .85 Guidelines for Terminating Use of Prescription Analgesics . .91 Headache Organizations and Resources . .92 Glossary of Terms . .93 Slides . .95 Revised January 2004 Agenda • Introduction • Module 1 Prevalence and Impact of Migraine • Module 2 Migraine Mechanisms • Module 3 History, Physical and Diagnosis • Module 4 Migraine Management • Conclusions • Question and Answer Session Introduction The American Headache Society (AHS) welcomes you to Brainstorm—The Primary Care Migraine Partnership’s collaborative, interactive educational program. The Primary Care Migraine Partnership is an innovative educational program designed by primary care physicians and neurologists for primary care physicians. This dynamic program results from an extensive needs assessment, including a comprehensive review of the primary care literature and more than 80 hours of interviews with primary care physicians regarding the challenges faced in treating migraine patients. To make Brainstorm possible, 18 primary care and neurologist thought leaders on migraine met to review the information that had been collected and design key educational messages. From this effort, a smaller team of dedicated primary care and headache specialist curriculum developers fashioned this exciting program. Together, we’re going to explore the many dimensions of migraine through an interactive, patient-oriented, case-based program.